Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)
Clinical trial NCT00092482 · COMPLETED
Trial details
- NCT number
- NCT00092482
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-28
- Primary completion
- 2004-06-30
- Enrollment
- 3882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.